Where do UK clinicians find information at the point of care? A pragmatic, exploratory study.

Autor: McCartney, Margaret¹ (AUTHOR) mm494@st-andrews.ac.uk, Connolly, Kate¹ (AUTHOR), Sullivan, Frank¹ (AUTHOR), Heneghan, Carl² (AUTHOR), Heng Ho, Elijah Yu¹ (AUTHOR), Hendry, Brid³ (AUTHOR), Salisbury, Charlotte¹ (AUTHOR), Offer, Sam¹ (AUTHOR), Nunan, David² (AUTHOR)

Publikováno v: BMC Primary Care. 10/23/2024, Vol. 25 Issue 1, p1-8. 8p.

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

Autor: Gershenson, David M ^*, Miller, Austin, Brady, William E, Paul, James, Carty, Karen, Rodgers, William, Millan, David, Coleman, Robert L, Moore, Kathleen N, Banerjee, Susana, Connolly, Kate, Secord, Angeles Alvarez, O'Malley, David M, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robert L, Herrington, C Simon, Huang, Helen Q, Wenzel, Lari, Gourley, Charlie

Publikováno v: In The Lancet 5-11 February 2022 399(10324):541-553

Dark Web Marketplaces: Data for Collaborative Threat Intelligence.

Autor: Connolly, Kate, Klempay, Anna, McCann, Mary, Brenner, Paul

Publikováno v: Digital Threats: Research & Practice; Dec2023, Vol. 4 Issue 4, p1-12, 12p

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): a randomised, open-label phase 2/3 trial

Autor: M. Gershenson, David, Miller, Austin, E Brady, William, Paul, James, Carty, Karen, Rodgers, William, Millan, David, L Coleman, Robert, N Moore, Kathleen, Banerjee, Susana, Connolly, Kate, Alvarez Secord, Angeles, M O'Malley, David, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robb, Herrington, C Simon, Q Huang, Helen, B Wenzel, Lari, Gourley, Charlie

Publikováno v: M. Gershenson, D, Miller, A, E Brady, W, Paul, J, Carty, K, Rodgers, W, Millan, D, L Coleman, R, N Moore, K, Banerjee, S, Connolly, K, Alvarez Secord, A, M O'Malley, D, Dorigo, O, Gaillard, S, Gabra, H, Slomovitz, B, Hanjani, P, Farley, J, Churchman, M, Ewing, A, Hollis, R, Herrington, C S, Q Huang, H, B Wenzel, L & Gourley, C 2022, ' Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): a randomised, open-label phase 2/3 trial ', The Lancet, vol. 399, no. 10324, pp. 541-553 . https://doi.org/10.1016/S0140-6736(21)02175-9

BACKGROUND: Low-grade serous carcinoma of the ovary or peritoneum is characterised by MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high-grade serous carcinoma. We compared the MEK inhibitor trametinib to physician'

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3094::10daf3830e8817199b8469c4d2ece72c
https://hdl.handle.net/20.500.11820/745251c7-7e6d-4cf1-9129-3a76f1637764

When Amazon ate Whole Foods: big changes for Big Food

Autor: Phillips-Connolly, Kate, Connolly, Aidan J.

The grocery store is ground zero in the tsunami of change facing Big Food. Consumers are changing how they relate to grocery stores, increasingly circling the perimeter, focusing on produce and preferentially choosing fresh, local, and new, even unkn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a58d77358e6ca1bd12bb77a62477bbd1